The Treatment of Depressive Disorders in Children and Adolescents
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Depressive disorders are among the more common mental illnesses around the world. About 3% of prepubertal children and 6% of postpubertal children and adolescents are affected. Many physicians are unsure about which treatment approaches are effective and how the treatment should be planned. METHOD: A systematic literature search was carried out in electronic databases and study registries and as a manual search. More than 450 studies (mostly randomized controlled trials [RCTs]) were identified and summarized in five evidence tables. The ensuing recommendations were agreed upon in a consensus conference in which 23 organizations were represented. RESULTS: The recommended treatment of first choice for children from age 8 onward and for adolescents is either cognitive behavioral therapy (CBT) (Cohen's d [effect strength]: 0.5-2) or interpersonal psychotherapy (Cohen's d: 0.5-0.6). Fluoxetine is recommended for drug treatment (Cohen's d: 0.3-5.6), either alone or in combination with CBT. The analysis revealed a lower level of evidence for psychodynamic or systemic psychotherapy or for drug treatment with escitalopram, citalopram, or sertraline. For mild or moderate depression, psychotherapy is recommended; for severe depression, combination therapy. Particularly for children, there is a lack of adequately informative comparative studies on these treatment approaches as well as on other, complementary interventions (e.g., art therapy, sleep deprivation, youth welfare services). CONCLUSION: There is adequate evidence to support some recommendations for the treatment of depressive disorders in adolescents, but evidence for children is lacking. There is a pressing need for intervention research in this area for both children and adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Is there an epidemic of child or adolescent depression?
Jane Costello, E., Erkanli, A., & Angold, A. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01682.x · Cited by 983
Attachment-Based Family Therapy for Depressed Adolescents: A Treatment Development Study
DIAMOND, G. S., REIS, B. F., DIAMOND, G. M., SIQUELAND, L., & ISAACS, L. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200210000-00008 · Cited by 382
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management
Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., Stein, R. E. K., & and the GLAD-PC Steering Group (2007) · Pediatrics · doi:10.1542/peds.2006-1395 · Cited by 336
Newer generation antidepressants for depressive disorders in children and adolescents
Hetrick, S. E., McKenzie, J. E., Cox, G. R., Simmons, M. B., & Merry, S. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004851.pub3 · Cited by 291
Emslie, G. J., Ventura, D., Korotzer, A., & Tourkodimitris, S. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181a2b304 · Cited by 210
Tricyclic drugs for depression in children and adolescents
Hazell, P., O'Connell, D., Heathcote, D., & Henry, D. A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002317 · Cited by 167
Combined treatment with cognitive–behavioural therapy in adolescent depression: meta-analysis
Dubicka, B., Elvins, R., Roberts, C., Chick, G., Wilkinson, P., & Goodyer, I. M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.075853 · Cited by 116 · cited 1×
“The recommended treatment of first choice for older children and adolescents with depressive disorders of various degrees of severity, and for those with a first episode of a depressive disorder, is either CBT, or interpersonal psychotherapy, or fluoxetine, or a combination of CBT and fluoxetine (12, 13) (strong recom…”
Backgroundvon Knorring, A.-L., Olsson, G. I., Thomsen, P. H., Lemming, O. M., & Hultén, A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000219051.40632.d5 · Cited by 111
KROLL, L., HARRINGTON, R., JAYSON, D., FRASER, J., & GOWERS, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199609000-00013 · Cited by 106
Cited by
Murphy, S. E., Capitão, L. P., Giles, S. L. C., Cowen, P. J., Stringaris, A., & Harmer, C. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00154-1 · Cited by 112
Wunram, H. L., Hamacher, S., Hellmich, M., Volk, M., Jänicke, F., Reinhard, F., Bloch, W., Zimmer, P., Graf, C., Schönau, E., et al. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1071-2 · Cited by 56
“Participants included into the study performed the following physical examinations before starting the intervention (t0), after 6 weeks intervention (t1) and after 8 weeks without exercise intervention (t2): spiroergometry (using systems ZAN®, Blue Cherry and ergometer-cycle ergoline®) with electrocardiography (AMEDTE…”
BackgroundInfluentialBernal-Morales, B., Rodríguez-Landa, J. F., & Pulido-Criollo, F. (2015) · A Fresh Look at Anxiety Disorders · doi:10.5772/60711 · Cited by 45
Reinauer, C., Platzbecker, A. L., Viermann, R., Domhardt, M., Baumeister, H., Foertsch, K., Linderskamp, H., Krassuski, L., Staab, D., Minden, K., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.27622 · Cited by 22
Oberste, M., Großheinrich, N., Wunram, H.-L., Graf, J. L., Ziemendorff, A., Meinhardt, A., Fricke, O., Mahabir, E., & Bender, S. (2018) · Trials · doi:10.1186/s13063-018-2747-8 · Cited by 15
Metadata
- Authors
- Dolle, K., & Schulte-Körne, G.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2013-12-13
- Volume
- 110
- Issue
- 50
- Pages
- 854-60
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W2187356615
- Cited by
- 45
- References
- 13
- FWCI
- 3.88
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.